{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:45:24Z","timestamp":1790095524142,"version":"4.0.1"},"reference-count":30,"publisher":"BMJ","issue":"12","funder":[{"name":"Miles of migraine","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Patient philantropy","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Reg Anesth Pain Med"],"accepted":{"date-parts":[[2023,4,19]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Subanesthetic ketamine infusion has been used for managing refractory headache in inpatient or outpatient infusion settings. Intranasal ketamine may be an alternative option for outpatient care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective study was conducted at a single tertiary headache center to assess the clinical effectiveness and tolerability of intranasal ketamine in patients with refractory chronic migraine. Candidates who received intranasal ketamine between January 2019 and February 2020 were screened through an electronic medical record query. Manual chart reviews and structured telephone interviews were conducted on obtaining informed consent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 242 subjects screened, 169 (79.9% women) of median (IQR) age 44 (22) years were interviewed. They reported a median (IQR) of 30 (9) monthly headache days and tried 4 (1) classes of preventive medications. Overall, they used 6 (6) sprays per day, with a median (IQR) of spray use of 10 (11) days per month. Intranasal ketamine was reported as \u2018very effective\u2019 in 49.1% and the quality of life was considered \u2018much better\u2019 in 35.5%. At the time of the interview, 65.1% remained current intranasal ketamine users and 74.0% reported at least one adverse event.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In this descriptive study, intranasal ketamine served as an acute treatment for refractory chronic migraine by reducing headache intensity and improving quality of life with relatively tolerable adverse events. Most patients found intranasal ketamine effective and continued to use it despite these adverse events. Given the potential for overuse, it should be reserved for those clearly in need of more effective rescue treatment with appropriate safety precautions. Well-designed prospective placebo-controlled trials are necessary to demonstrate the efficacy and safety of intranasal ketamine in patients with migraine.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rapm-2022-104223","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:06:16Z","timestamp":1685491576000},"page":"581-587","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis"],"prefix":"10.1136","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4536-9974","authenticated-orcid":false,"given":"Hsiangkuo","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniket","family":"Natekar","sequence":"additional","affiliation":[{"name":"Neurology, OhioHealth, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Neurology, Rush University, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton G","family":"Lauritsen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0260-4396","authenticated-orcid":false,"given":"Eugene R","family":"Viscusi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Marmura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"2025101110570476000_48.12.581.1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01130-5"},{"key":"2025101110570476000_48.12.581.2","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000707"},{"key":"2025101110570476000_48.12.581.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2010.09.021"},{"key":"2025101110570476000_48.12.581.4","doi-asserted-by":"publisher","DOI":"10.1124\/pr.117.015198"},{"key":"2025101110570476000_48.12.581.5","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.672526"},{"key":"2025101110570476000_48.12.581.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2017.02.035"},{"key":"2025101110570476000_48.12.581.7","doi-asserted-by":"publisher","DOI":"10.1038\/nature17998"},{"key":"2025101110570476000_48.12.581.8","doi-asserted-by":"publisher","DOI":"10.1124\/mol.120.119784"},{"key":"2025101110570476000_48.12.581.9","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1920"},{"key":"2025101110570476000_48.12.581.10","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-021-00977-w"},{"key":"2025101110570476000_48.12.581.11","doi-asserted-by":"publisher","DOI":"10.17245\/jdapm.2021.21.5.413"},{"key":"2025101110570476000_48.12.581.12","doi-asserted-by":"publisher","DOI":"10.1111\/head.13013"},{"key":"2025101110570476000_48.12.581.13","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000827"},{"key":"2025101110570476000_48.12.581.14","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S203650"},{"key":"2025101110570476000_48.12.581.15","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/77.2.203"},{"key":"2025101110570476000_48.12.581.16","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202104_25738"},{"key":"2025101110570476000_48.12.581.17","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10173978","article-title":"Efficacy and safety of intranasal ketamine for acute pain management in the emergency setting: a systematic review and meta-analysis","volume":"10","author":"Seak","year":"2021","journal-title":"J Clin Med"},{"key":"2025101110570476000_48.12.581.18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.1.139"},{"key":"2025101110570476000_48.12.581.19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182824e66"},{"key":"2025101110570476000_48.12.581.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2018.12.007"},{"key":"2025101110570476000_48.12.581.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2019.10.007"},{"key":"2025101110570476000_48.12.581.22","doi-asserted-by":"publisher","DOI":"10.1111\/head.14220"},{"key":"2025101110570476000_48.12.581.23","doi-asserted-by":"publisher","DOI":"10.1186\/s13005-021-00303-0"},{"key":"2025101110570476000_48.12.581.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"2025101110570476000_48.12.581.25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/4602651","article-title":"Nasal delivery devices: a comparative study on cadaver model","volume":"2019","author":"Moffa","year":"2019","journal-title":"BioMed Res Int"},{"key":"2025101110570476000_48.12.581.26","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-012-0121-z"},{"key":"2025101110570476000_48.12.581.27","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25215188","article-title":"Shortcut approaches to substance delivery into the brain based on intranasal administration using nanodelivery strategies for insulin","volume":"25","author":"Tashima","year":"2020","journal-title":"Molecules"},{"key":"2025101110570476000_48.12.581.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227762","article-title":"Pharmacokinetics, absolute bioavailability and tolerability of ketamine after intranasal administration to dexmedetomidine sedated dogs","volume":"15","author":"Vlerick","year":"2020","journal-title":"PLoS One"},{"key":"2025101110570476000_48.12.581.29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40263-022-00930-4","article-title":"Using the intranasal route to administer drugs to treat neurological and psychiatric illnesses: rationale, successes, and future needs","volume":"36","author":"Lofts","year":"2022","journal-title":"CNS Drugs"},{"key":"2025101110570476000_48.12.581.30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpsychires.2019.02.003","article-title":"Brain penetration of ketamine: intranasal delivery vs parenteral routes of administraion","volume":"112","author":"Naidoo","year":"2019","journal-title":"J Psychiatr Res"}],"container-title":["Regional Anesthesia &amp; Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rapm-2022-104223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:57:20Z","timestamp":1760205440000},"score":1,"resource":{"primary":{"URL":"https:\/\/rapm.bmj.com\/lookup\/doi\/10.1136\/rapm-2022-104223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,10,25]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/rapm-2022-104223"],"URL":"https:\/\/doi.org\/10.1136\/rapm-2022-104223","relation":{},"ISSN":["1098-7339","1532-8651"],"issn-type":[{"value":"1098-7339","type":"print"},{"value":"1532-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]}}}